Journal of Glaucoma · 2010 · 44 citations · 19 references
PharmacyClinical PharmacyPharmacotherapyOcular PharmacologyPharmaceutical CompliancePharmacovigilanceGlaucomaGlaucoma MonitoringMedication AdherencePatient AdherencePharmacotherapy MonitoringAdherenceMedication Coverage DeterminationsOcular Hypertension TreatmentTopical Medication AdministrationTreatment Efficacy Monitoring
PURPOSE: To assess the patient adherence and behavior with brimonidine twice daily (bid) or 3 times daily (tid) in patients used to topical glaucoma medication. PATIENTS AND METHODS: Seventy-five patients with glaucoma or ocular hypertension were enrolled in a prospective, observational cohort study. Consenting patients were randomly assigned to brimonidine bid or tid and received conventional brimonidine eye drops with attached electronic monitoring devices for 4 weeks. Patients were not explicitly informed on the compliance monitoring. RESULTS: The study was completed by 67 patients (89%). In 65 patients (97%), at least 1 dosing interval exceeded 24 hours. The mean adherence rates were better in the brimonidine bid group (72 ± 19% vs. 62 ± 16%, P=0.04), although dosing frequency was higher in the tid group (1.9 ± 0.5 vs. 1.4 ± 0.4 per day; P<0.001). On average medication coverage was 70% for the bid group and 67% for the tid group; 19 patients (28%) had a coverage rate above 75%, 42 patients (63%) 50% to 75%, and 6 (9%) below 50%. Patients with normal-tension glaucoma had lower coverage rates than patients with primary open-angle glaucoma and ocular hypertension (P<0.05). Data also showed that on average 20% of the glaucoma medication was wasted owing to inefficient drug delivery by using more than 1 drop per dosing. CONCLUSIONS: Individual adherence with brimonidine was highly variable and pharmacologically insufficient for more than two-third of the patients. Special attention should be paid to compliance of patients with normal-tension glaucoma. Our findings underline the need to improve individual adherence and drug delivery in topical glaucoma therapy.
19
The Ocular Hypertension Treatment Study
Michael A. Kass · Archives of Ophthalmology · 2002 · 3.7K citations · Full text
Reduction of Intraocular Pressure and Glaucoma Progression
Anders Heijl · Archives of Ophthalmology · 2002 · 3.3K citations
Persistence and Adherence With Topical Glaucoma Therapy
Beth Nordstrom, David S. Friedman, Essy Mozaffari et al. · American Journal of Ophthalmology · 2005 · 470 citations
Compliance Barriers in Glaucoma: A Systematic Classification
James C. Tsai, Cori A. McClure, Sarah E. Ramos et al. · Journal of Glaucoma · 2003 · 402 citations
Compliance with Topical Pilocarpine Treatment
Michael A. Kass, David W. Meltzer, Mae O. Gordon et al. · American Journal of Ophthalmology · 1986 · 340 citations